Collateral chemoresistance to anti-microtubule agents in a lung cancer cell line with acquired resistance to erlotinib.
about
Acquired nintedanib resistance in FGFR1-driven small cell lung cancer: role of endothelin-A receptor-activated ABCB1 expressionRepurposing FDA-approved drugs as therapeutics to treat Rift Valley fever virus infection.Oncogene swap as a novel mechanism of acquired resistance to epidermal growth factor receptor-tyrosine kinase inhibitor in lung cancerRole of EGFR mutations in lung cancers: prognosis and tumor chemosensitivity.Therapy-induced E-cadherin downregulation alters expression of programmed death ligand-1 in lung cancer cells.Afatinib in lung cancer harboring EGFR mutation in the LUX-Lung trials: six plus three is greater than seven?Elacridar, a third-generation ABCB1 inhibitor, overcomes resistance to docetaxel in non-small cell lung cancer.
P2860
Q30365571-93F214D1-AF63-4EE1-A6E1-E1D829CEC32FQ35718193-43D5E152-BF0E-465E-B8C8-2D8E9A67B061Q36801144-773EA3C3-5B34-408F-B794-6266B6487918Q38486882-43B8F607-68AC-49FC-8DAC-EC59016CE16FQ38746756-F5A28D84-0DE1-4D49-9DAE-A7D13C2E1930Q41001615-1E47B6BE-0C5A-43DE-85FE-5411F2567374Q41676866-6EE13ED2-AC24-4942-868A-F54167039DB4
P2860
Collateral chemoresistance to anti-microtubule agents in a lung cancer cell line with acquired resistance to erlotinib.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Collateral chemoresistance to ...... uired resistance to erlotinib.
@ast
Collateral chemoresistance to ...... uired resistance to erlotinib.
@en
type
label
Collateral chemoresistance to ...... uired resistance to erlotinib.
@ast
Collateral chemoresistance to ...... uired resistance to erlotinib.
@en
prefLabel
Collateral chemoresistance to ...... uired resistance to erlotinib.
@ast
Collateral chemoresistance to ...... uired resistance to erlotinib.
@en
P2093
P2860
P50
P1433
P1476
Collateral chemoresistance to ...... uired resistance to erlotinib.
@en
P2093
Hiroshi Mizuuchi
Katsuaki Sato
Kazuto Nishio
Shuta Tomida
Yoshihiko Fujita
Yoshihisa Kobayashi
Yoshitaka Sekido
P2860
P304
P356
10.1371/JOURNAL.PONE.0123901
P407
P577
2015-04-14T00:00:00Z